319
Views
2
CrossRef citations to date
0
Altmetric
Environmental Determinants

Respiratory tract infection-induced asthma exacerbations in adults with asthma: assessing predictors and outcomes

, PharmD, PhD, , PharmD, MS, , PharmD, PhD & , PhD
Pages 231-240 | Received 25 May 2018, Accepted 06 Jan 2019, Published online: 04 Feb 2019

References

  • Loftus PA, Wise SK. Epidemiology and economic burden of asthma. Int Forum Allergy Rhinol 2015;5:S7–S10.
  • Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM, et al. Economic burden of asthma: a systematic review. BMC Pulm Med. 2009;9:24.
  • Collaborators GDaIIaP. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1545–1602. doi:10.1016/S0140-6736(16)31678-6.
  • To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, Boulet L-P. Global asthma prevalence in adults: findings from the cross-sectional world health survey. BMC Public Health. 2012;12:204.
  • American Lung Association. Trends in asthma morbidity and mortality. American Lung Association. Epidemiology and Statistics. 2012 [accessed 3 Nov 2017]. Available from: https://www.lung.org/assets/documents/research/asthma-trend-report.pdf.
  • Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2016. [accessed 30 October 2017]. Available from: http://www.ginasthma.org.
  • Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004;59:469–478. doi:10.1111/j.1398-9995.2004.00526.x.
  • Sullivan PW, Slejko JF, Ghushchyan VH, Sucher B, Globe DR, Lin S-L, Globe G, et al. The relationship between asthma, asthma control and economic outcomes in the United States. J Asthma 2014;51:769–778.
  • Jordan Health Systems Profile. Regional Health Systems Observatory-EMRO; 2006. Available from: http://apps.who.int/medicinedocs/documents/s17296e/s17296e.pdf (last accessed 10 Feb 2018).
  • The National Strategy for Health Sector in Jordan 2015–2019. Available from: http://www.hhc.gov.jo/uploadedimages/The National Strategy for Health Sector in Jordan 2015-2019.pdf (accessed 21 Apr 2018).
  • Masjedi M, Ainy E, Zayeri F, Paydar R. Assessing the prevalence and incidence of asthma and chronic obstructive pulmonary disease in the Eastern Mediterranean Region. Turk Thorac J. 2018;19:56–60. doi:10.5152/TurkThoracJ.2018.17051.
  • Enright PL, McClelland RL, Newman AB, Gottlieb DJ, Lebowitz MD. Underdiagnosis and undertreatment of asthma in the elderly. Cardiovascular Health Study Research Group. Chest 1999;116:603–613.
  • Gillman A, Douglass JA. Asthma in the elderly. Asia Pac Allerg. 2012;2:101–108.
  • Bousquet J, Bousquet PJ, Godard P, Daures JP. The public health implications of asthma. Bull World Health Organ. 2005;83:548–554.
  • Plaza V, Serra-Batlles J, Ferrer M, Morejón E. Quality of life and economic features in elderly asthmatics. Respiration 2000;67:65–70.
  • Treitel M, Marbury T, Preston RA, Triantafyllou I, Feely W, O'Mara E, Kasserra C, et al. Single-dose pharmacokinetics of boceprevir in subjects with impaired hepatic or renal function. Clin Pharmacokinet. 2012;51:619–628.
  • Atmar RL, Guy E, Guntupalli KK, Zimmerman JL, Bandi VD, Baxter BD, Greenberg SB, et al. Respiratory tract viral infections in inner-city asthmatic adults. Arch Int Med. 1998;158:2453–2459.
  • Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ 1993;307:982–986.
  • Corne JM, Marshall C, Smith S, Schreiber J, Sanderson G, Holgate ST, Johnston SL, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet 2002;359:831–834.
  • Ban GY, Trinh TH, Ye YM, Park HS. Predictors of asthma control in elderly patients. Curr Opin Allergy Clin Immunol. 2016;16:237–243.
  • Lainscak M, Anker SD. Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challenges. ESC Heart Fail. 2015;2:103–107. doi:10.1002/ehf2.12055.
  • Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33:897–906.
  • Darveaux JI, Lemanske RF. Jr. Infection-related asthma. J Allergy Clin Immunol Pract. 2014;2:658–663.
  • Raina SK. Ratio of controls to cases: a design decision. J Postgrad Med. 2014;60:414.
  • Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, Casaburi R, Coates A, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26:948–968.
  • Lee CH, Jang EJ, Hyun MK, Lee NR, Kim K, Yim JJ. Risk of hospital admission or emergency room visit for pneumonia in patients using respiratory inhalers: a case-crossover study. Respirology 2013;18:1116–1127.
  • Prazma CM, Kral KM, Gul N, Yancey SW, Stempel DA. Controller medications and their effects on asthma exacerbations temporally associated with upper respiratory infections. Respir Med. 2010;104:780–787.
  • Coraux C, Kileztky C, Polette M, Hinnrasky J, Zahm J-M, Devillier P, de Bentzmann S, et al. Airway epithelial integrity is protected by a long-acting beta2-adrenergic receptor agonist. Am J Respir Cell Mol Biol. 2004;30:605–612. doi:10.1165/rcmb.2003-0056OC.
  • Dowling RB, Johnson M, Cole PJ, Wilson R. Effect of salmeterol on Haemophilus influenzae infection of respiratory mucosa in vitro. Eur Respir J. 1998;11:86–90. doi:10.1183/09031936.98.11010086.
  • Dowling RB, Johnson M, Cole PJ, Wilson R. Effect of fluticasone propionate and salmeterol on Pseudomonas aeruginosa infection of the respiratory mucosa in vitro. Eur Respir J. 1999;14:363–369.
  • Kanthakumar K, Cundell DR, Johnson M, Wills PJ, Taylor GW, Cole PJ, Wilson R, et al. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin. Br J Pharmacol. 1994;112:493–498.
  • Winter MC, Shasby SS, Ries DR, Shasby DM. PAR2 activation interrupts E-cadherin adhesion and compromises the airway epithelial barrier: protective effect of beta-agonists. Am J Physiol Lung Cell Mol Physiol. 2006;291:L628–L635.
  • Eisner MD, Yegin A, Trzaskoma B. Severity of asthma score predicts clinical outcomes in patients with moderate to severe persistent asthma. Chest 2012;141:58–65.
  • Hermosa JL, Sanchez CB, Rubio MC, Minguez MM, Walther JL. Factors associated with the control of severe asthma. J Asthma 2010;47:124–130.
  • Reddel H, Ware S, Marks G, Salome C, Jenkins C, Woolcock A. Differences between asthma exacerbations and poor asthma control. Lancet 1999;353:364–369.
  • Perez De Llano LA, Gonzalez FC, Anon OC, Perea MP, Caruncho MV, Villar AB. Relationship between comorbidity and asthma control. Arch Bronconeumol. 2010;46:508–513.
  • Hsiao H-J, Wang L-C, Yang Y-H, Lee J-H, Yu H-H, Lin Y-T, Chiang B-L. A nationwide survey of the severity, comorbidity, and mortality of hospitalized patients with asthma in Taiwan. Pediatr Neonatol. 2013;54:254–260. doi:10.1016/j.pedneo.2013.01.017.
  • Piecoro LT, Potoski M, Talbert JC, Doherty DE. Asthma prevalence, cost and adherence with expert guidelines on the utilization of health care services and costs in a state Medicaid population. Health Serv Res. 2001;36:357–372.
  • Szucs TD, Anderhub H, Rutishauser M. The economic burden of asthma: direct and indirect costs in Switzerland. Eur Respir J. 1999;13:281–286.
  • Shaya FT, Dongyi D, Akazawa MO, Blanchette CM, Wang J, Mapel DW, Dalal A, et al. Burden of concomitant asthma and COPD in a Medicaid population. Chest 2008;134:14–19.
  • Shah R, Yang Y. Health and economic burden of obesity in elderly individuals with asthma in the United States. Popul Health Manage. 2015;18:186–191.
  • National Asthma Education and Prevention Program, Third Expert Panel on the Management of Asthma, National Center for Biotechnology I. Expert Panel report 3: guidelines for the diagnosis and management of asthma. Bethesda, MD: U.S. Dept. of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute; 2007. http://www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf.
  • Pradeepan S, Garrison G, Dixon AE. Obesity in asthma: approaches to treatment. Curr Allerg Asthma Rep. 2013;13:434–442.
  • Vaidya V, Holiday-Goodman M, Pinto S. Demographic disparities in patient-reported use of inhaled corticosteroids among patients with persistent asthma. J Asthma Allerg. 2010;3:101–106.
  • Guhan AR, Cooper S, Oborne J, Lewis S, Bennett J, Tattersfield AE. Systemic effects of formoterol and salmeterol: a dose-response comparison in healthy subjects. Thorax 2000;55:650–656.
  • Palatini P, Casiglia E, Julius S, Pessina AC. High heart rate: a risk factor for cardiovascular death in elderly men. Arch Int Med. 1999;159:585–592.
  • Salpeter SR, Ormiston TM, Salpeter EE. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest 2004;125:2309–2321.
  • Ofoma UR, Lehman E, Sciamanna C. Undertreated and uncontrolled asthma among US adults: findings from a national sample. D34 ASTHMA EPIDEMIOLOGY. p. A5690-A. Available from: https://www.atsjournals.org/action/showCitFormats?doi=10.1164%2Fajrccmconference.2012.185.1_MeetingAbstracts.A5690
  • Nolte H, Nepper-Christensen S, Backer V. Unawareness and undertreatment of asthma and allergic rhinitis in a general population. Respir Med. 2006;100:354–362. doi:10.1016/j.rmed.2005.05.012.
  • Firoozi F, Lemiere C, Beauchesne MF, Forget A, Blais L. Development and validation of database indexes of asthma severity and control. Thorax 2007;62:581–587.
  • Jacob C, Haas JS, Bechtel B, Kardos P, Braun S. Assessing asthma severity based on claims data: a systematic review. Eur J Health Econ. 2017;18:227–241. doi:10.1007/s10198-016-0769-2.
  • Bellia V, Battaglia S, Catalano F, Scichilone N, Incalzi RA, Imperiale C, Rengo F, et al. Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. Chest 2003;123:1066–1072.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.